Evidence map›Paper›PMID 41468606›Full record

Trial reportJMIR formative research2025

Feasibility and Usability of an mHealth App (mLab+) to Guide Users Through HIV and Syphilis Self-Testing: Pilot Randomized Controlled Trial.

Maeve Brin, Thomas F Scherr, Janejira Chaiyasit, Jianfang Liu, Maura Abbott, Robert Garofalo, Lisa M Kuhns, Tess Sky, Ian Esliker, Rebecca Schnall

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JMIR formative research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Maeve BrinSchool of Nursing, Columbia University, 560 W 168 Street, New York, NY, 10032, United States, 1 212-342-6886.ORCID 0009-0006-1625-3450
Thomas F ScherrVanderbilt University, Nashville, United States.ORCID 0000-0002-7077-535X
Janejira ChaiyasitMGH Institute of Health Professions School of Nursing, Washington DC, United States.ORCID 0000-0001-5172-6846
Jianfang LiuSchool of Nursing, Columbia University, 560 W 168 Street, New York, NY, 10032, United States, 1 212-342-6886.ORCID 0000-0003-3546-0800
Maura AbbottMGH Institute of Health Professions School of Nursing, Washington DC, United States.ORCID 0000-0002-2354-9405
Robert GarofaloDivision of Adolescent & Young Adult Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.ORCID 0000-0001-9513-9416
Lisa M KuhnsDivision of Adolescent & Young Adult Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, United States.ORCID 0000-0001-8294-7801
Tess SkyMGH Institute of Health Professions School of Nursing, Washington DC, United States.ORCID 0009-0006-0823-6335
Ian EslikerSchool of Nursing, Columbia University, 560 W 168 Street, New York, NY, 10032, United States, 1 212-342-6886.ORCID 0009-0004-4796-4875
Rebecca SchnallSchool of Nursing, Columbia University, 560 W 168 Street, New York, NY, 10032, United States, 1 212-342-6886.ORCID 0000-0003-2184-4045

Funding

Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI APRIL PETTIT · 2015 to 2026
$27.5M
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among Young MenUH3AI169658 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Dustin T Duncan, Robert Garofalo · 2024 to 2026
$5.0M
mLab App for Improving Uptake of rapid HIV self-testing and Linking Youth to CareR01MH118151 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GAROFALO, ROBERT, SCHNALL, REBECCA · 2018 to 2022
$4.1M
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSMUG3AI169658 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DUNCAN, DUSTIN T, GAROFALO, ROBERT · 2022 to 2023
$3.8M
Mentoring and Research in Self-Management for Health Promotion and Disease PreventionK24NR018621 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI SCHNALL, REBECCA · 2019 to 2022
$384k
NIAID NIH HHS P30 AI110527NIAID NIH HHS UG3 AI169658NIAID NIH HHS UH3 AI169658NIMH NIH HHS R01 MH118151NINR NIH HHS K24 NR018621
6 · The paper itself

Abstract

Background: HIV self-testing is an important strategy in the US Ending the HIV Epidemic initiative. To facilitate uptake of self-testing, we developed the mLab app, which complements existing self-test options to support the potential for higher uptake of the HIV self-test. Syphilis, a sexually transmitted infection with currently rising prevalence and overlap in risk profiles with HIV, could similarly benefit from the advantages of companion diagnostic mobile apps such as mLab. Due to the success of the mLab app in promoting HIV self-testing during a randomized controlled trial and the scientific evidence of need for at-home syphilis testing, our team developed the mLab+ app, which supports both HIV and syphilis testing through an image processing algorithm that incorporates a duplex HIV and syphilis point-of-care test. Objective: We conducted a pilot study to assess the feasibility and usability of the mLab+ app for HIV and syphilis testing. Methods: We recruited participants who were assigned male sex at birth and reported sex with another man. Participants came to the Nurse Practitioner Group clinic for baseline and follow-up visits. Participants rated the usability of the app using the Health Information Technology Usability Evaluation Scale and the Post-Study System Usability Questionnaire at their 3-month follow-up visit. The primary outcome was the number of participants who were able to self-administer the DPP HIV-Syphilis test with the assistance of the mLab+ app. Feasibility was measured through recruitment pace, retention over 3 months, app usability, and paradata. Results: Of the 20 participants, 19 identified as male and 1 identified as nonbinary. Most participants (n=16) were able to complete the DPP HIV-Syphilis test with facilitation support from the mLab+ app. The average duration of an app session, from after authentication until log-out or abandonment, was 30 minutes and 33 seconds (SD 21 minutes and 40 seconds). Apart from the 27% (13/48) of sessions that were 5 minutes or less, the distribution of session durations was approximately normal. Users spent the longest time viewing testing screens (ie, timer screens, initial testing screen, test guided walkthroughs, test results, and picture and result upload). The overall mean scores on the Post-Study System Usability Questionnaire (2.65, SD 1.06) and Health Information Technology Usability Evaluation Scale (3.62, SD 1.07) indicated medium to high usability. The retention rate for the 3-month trial was 80% (16/20). Conclusions: The findings support the use of the mLab+ app as a tool for assisting consumers in self-testing for HIV and syphilis. The limitations of the study design warrant further examination outside of clinic settings to better understand the utility of these tools for improving consumer health outcomes.

Indexed as

HIV InfectionsMobile ApplicationsSelf-TestingSyphilisAdultFeasibility StudiesFemaleHumansMaleMiddle AgedPilot ProjectsSelf CareTelemedicineHIVmen who have sex with menmHealthmobile healthMSMself-testsexually transmitted infectionssyphilis

Identifiers

PMID41468606
PMCPMC12753130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.